Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6566334B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 5, 1998 |
| Grant date | May 20, 2003 |
| Priority date | — |
| Expiry date | Feb 5, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/903
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
“Minimalist” antimicrobial peptides are disclosed based on 50 to 80% &agr;,&agr;-dialkylated amino acids. The peptides are short, cationic, amphipathic, and possess a high helix propensity. Polar &agr;,&agr;-dialkylated amino acids are also disclosed. These peptides are easy and inexpensive to synthesize via solid-phase techniques. The peptides exhibit in vitro anti-bacterial properties at concentrations that are not lethal to normal mammalian cells. The peptides exhibit in vivo bioactivity against intracellular pathogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.